Fachbereich Biologie, Abt. Mikrobiologie, Technische Universität Kaiserslautern, Paul-Ehrlich-Str. 23, 67663, Kaiserslautern, Germany.
Microb Cell Fact. 2020 Oct 6;19(1):190. doi: 10.1186/s12934-020-01447-5.
Heme proteins and heme-derived molecules are essential in numerous cellular processes. Research into their in vitro functionality requires the production of large amounts of protein. Unfortunately, high yield expression is hampered by the lack of E. coli strains naturally capable of taking up heme from the medium. We recently reported the use of the probiotic E. coli strain Nissle 1917 (EcN) to sufficiently produce heme containing proteins, as it encodes the outer membrane heme receptor, ChuA, which allows for natural uptake of heme. The EcN strain however lacks the gene for T7 RNA polymerase, which is necessary for the expression of genes under the control of the T7-promotor, widely used in expression vectors like the pET or pDuet series.
A new T7-promoter compatible EcN strain was constructed by integrating the gene for T7-RNA polymerase under the control of a lacUV5 promoter into the malEFG operon of EcN. Test expressions of genes via T7 promoter-based vectors in the new EcN(T7) strain were successful. Expression in EcN(T7) resulted in the efficient production of recombinant heme proteins in which the heme cofactor was incorporated during protein production. In addition, the new EcN(T7) strain can be used to co-express genes for the production of heme-derived molecules like biliverdin or other linear tetrapyrroles. We demonstrate the successful recombinant production of the phytochromes BphP, from Pseudomonas aeruginosa, and Cph1, from Synechocystis sp. PCC6803, loaded with their linear tetrapyrrole cofactors, biliverdin and phycocyanobilin, respectively.
We present a new E. coli strain for efficient production of heme proteins and heme-derived molecules using T7-promoter based expression vectors. The new EcN(T7) strain enables the use of a broader spectrum of expression vectors, as well as the co-expression of genes using the pDuet expression vectors, for expressing heme containing proteins. By utilizing E. coli strains EcN and EcN(T7), capable of being fed heme, the rate limiting step of heme biosynthesis in E. coli is eliminated, thereby permitting higher heme saturation of heme proteins and also higher yields of heme-derived molecules.
血红素蛋白和血红素衍生分子在许多细胞过程中是必不可少的。研究它们的体外功能需要大量的蛋白质。不幸的是,由于缺乏能够从培养基中摄取血红素的大肠杆菌菌株,高产量表达受到阻碍。我们最近报道了使用益生菌大肠杆菌菌株 Nissle 1917(EcN)来充分生产含血红素的蛋白质,因为它编码外膜血红素受体 ChuA,允许自然摄取血红素。然而,EcN 菌株缺乏 T7 RNA 聚合酶基因,该基因对于受 T7 启动子控制的基因的表达是必需的,T7 启动子广泛用于表达载体,如 pET 或 pDuet 系列。
通过在 lacUV5 启动子的控制下将 T7 RNA 聚合酶基因整合到 EcN 的 malEFG 操纵子中,构建了一种新的与 T7 启动子兼容的 EcN 菌株。在新的 EcN(T7)菌株中通过 T7 启动子载体进行的基因测试表达是成功的。在 EcN(T7)中表达导致重组血红素蛋白的有效生产,其中血红素辅因子在蛋白质生产过程中被掺入。此外,新的 EcN(T7)菌株可用于共表达产生血红素衍生分子(如胆红素或其他线性四吡咯)的基因。我们成功地展示了来自铜绿假单胞菌的 phytochrome BphP 和来自集胞藻 PCC6803 的 Cph1 的重组生产,分别负载它们的线性四吡咯辅因子胆红素和藻红胆素。
我们提出了一种新的大肠杆菌菌株,用于使用 T7 启动子载体高效生产血红素蛋白和血红素衍生分子。新的 EcN(T7)菌株能够使用更广泛的表达载体,以及使用 pDuet 表达载体共表达基因,用于表达含血红素的蛋白质。通过利用能够摄取血红素的大肠杆菌菌株 EcN 和 EcN(T7),消除了大肠杆菌中血红素生物合成的限速步骤,从而允许血红素蛋白更高的血红素饱和度和血红素衍生分子的更高产量。